| Application no. and date | 99934698.4 (espacenet) (Federated) (European Patent Register), 19990715 | | Patent/reg. no. and date | DK/EP 1098898, 20021218 | | Publication date | 20010516 | | Priority no. and date | GB 9815567, 19980718 | | EP pub. no. and date |
EP 1098898 20010516 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB6 ONN, GB | | Applicant ref. no. | 34422 DK 01 | | Inventor | ARMITAGE, Ian, Gordon, 69 Ramerick Gardens,Arlesey
Bedfordshire SG15 6XZ, GB,
SEARLE, Andrew, David, Glaxo Wellcome plc,Gunnels Wood Road,Stevenage
Hertfordshire, GB,
SINGH, Hardev, Glaxo Wellcome plc,Temple Hill,Dartford
Kent DA1 5AH, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/665, C07F 9/655 | | Title | Calcium-(3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamat | | Int. application no. | PCT/EP99/04991 | | Int. publication no. | WO00004033 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
